Trends in net survival from stomach cancer in six European Latin countries: Results from the SUDCAN population-based study

L. Glória, N. Bossard, A.-M. Bouvier, A. Mayer-Da-Silva, J. Faivre, A. Miranda, GRELL EUROCARE-5 Working Group, Roberta De Angelis, Sandra Mallone, Massimiliano Caldora, Eugenio Carrani, Silvia Giovanna Luisa Francisci, Daniela Pierannunzio, Paolo Roazzi, Silvia Rossi, Mariano Santaquilani, andrea tavilla

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Gastric cancers are a clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from gastric cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and explore the trends in net survival and in the dynamics of the excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These trend analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in agestandardized net survival for stomach cancer (2000-2004). The 5-year net survival ranged between 26 (Spain) and 32% (Italy). There was a small increase in the age-standardized net survival at 1 year between 1992 and 2004. The increase was also observed in the 5-year net survival, except in France, where the increase was less marked. A slight decrease in the EMR between 1992 and 2004 was limited to the 24 months after diagnosis. In addition, the decrease in the EMR was the same whatever the year of diagnosis. There were minor differences in survival from stomach cancer between European Latin countries. A slight improvement in the 5-year net survival was observed in all countries and the major gain was observed during the 24 months after diagnosis. Development of innovative treatments is needed to improve the prognosis. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)S32-S39
JournalEuropean Journal of Cancer Prevention
Volume26
Issue number1
DOIs
Publication statusPublished - 2017

Fingerprint

Stomach Neoplasms
Mortality
Spain
Italy
Population
France
Portugal
Belgium
Switzerland
Demography
Databases
Health

Keywords

  • Cancer registries
  • Europe
  • Excess mortality rate
  • Net survival
  • Stomach cancer
  • Trend analysis
  • adolescent
  • adult
  • aged
  • Article
  • Belgium
  • cancer mortality
  • cancer prognosis
  • cancer survival
  • controlled study
  • experimental therapy
  • France
  • human
  • Italy
  • major clinical study
  • multicenter study
  • population research
  • Portugal
  • priority journal
  • Spain
  • stomach cancer
  • Switzerland
  • time
  • epidemiology
  • factual database
  • female
  • health survey
  • male
  • middle aged
  • mortality
  • procedures
  • register
  • stomach tumor
  • survival rate
  • trends
  • very elderly
  • young adult
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Databases, Factual
  • Female
  • Humans
  • Male
  • Middle Aged
  • Population Surveillance
  • Registries
  • Stomach Neoplasms
  • Survival Rate
  • Young Adult

Cite this

Trends in net survival from stomach cancer in six European Latin countries: Results from the SUDCAN population-based study. / Glória, L.; Bossard, N.; Bouvier, A.-M.; Mayer-Da-Silva, A.; Faivre, J.; Miranda, A.; Group, GRELL EUROCARE-5 Working; De Angelis, Roberta; Mallone, Sandra; Caldora, Massimiliano; Carrani, Eugenio; Francisci, Silvia Giovanna Luisa; Pierannunzio, Daniela; Roazzi, Paolo; Rossi, Silvia; Santaquilani, Mariano; tavilla, andrea.

In: European Journal of Cancer Prevention, Vol. 26, No. 1, 2017, p. S32-S39.

Research output: Contribution to journalArticle

@article{7da60710ddb04257be4df6586d1aa992,
title = "Trends in net survival from stomach cancer in six European Latin countries: Results from the SUDCAN population-based study",
abstract = "Gastric cancers are a clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from gastric cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and explore the trends in net survival and in the dynamics of the excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These trend analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in agestandardized net survival for stomach cancer (2000-2004). The 5-year net survival ranged between 26 (Spain) and 32{\%} (Italy). There was a small increase in the age-standardized net survival at 1 year between 1992 and 2004. The increase was also observed in the 5-year net survival, except in France, where the increase was less marked. A slight decrease in the EMR between 1992 and 2004 was limited to the 24 months after diagnosis. In addition, the decrease in the EMR was the same whatever the year of diagnosis. There were minor differences in survival from stomach cancer between European Latin countries. A slight improvement in the 5-year net survival was observed in all countries and the major gain was observed during the 24 months after diagnosis. Development of innovative treatments is needed to improve the prognosis. Copyright {\circledC} 2017 Wolters Kluwer Health, Inc. All rights reserved.",
keywords = "Cancer registries, Europe, Excess mortality rate, Net survival, Stomach cancer, Trend analysis, adolescent, adult, aged, Article, Belgium, cancer mortality, cancer prognosis, cancer survival, controlled study, experimental therapy, France, human, Italy, major clinical study, multicenter study, population research, Portugal, priority journal, Spain, stomach cancer, Switzerland, time, epidemiology, factual database, female, health survey, male, middle aged, mortality, procedures, register, stomach tumor, survival rate, trends, very elderly, young adult, Adolescent, Adult, Aged, Aged, 80 and over, Databases, Factual, Female, Humans, Male, Middle Aged, Population Surveillance, Registries, Stomach Neoplasms, Survival Rate, Young Adult",
author = "L. Gl{\'o}ria and N. Bossard and A.-M. Bouvier and A. Mayer-Da-Silva and J. Faivre and A. Miranda and Group, {GRELL EUROCARE-5 Working} and {De Angelis}, Roberta and Sandra Mallone and Massimiliano Caldora and Eugenio Carrani and Francisci, {Silvia Giovanna Luisa} and Daniela Pierannunzio and Paolo Roazzi and Silvia Rossi and Mariano Santaquilani and andrea tavilla",
note = "Cited By :1 Export Date: 11 April 2018 CODEN: EJUPE Correspondence Address: Miranda, A.; Department of Epidemiology, South Regional Cancer Registry (ROR-Sul), Instituto Portugu{\^e}s de Oncologia de Lisboa, Francisco Gentil, E.P.E, Rua Professor Lima Basto, Portugal; email: amcbpcm@gmail.com Funding details: 20102202 Funding details: Compagnia di San Paolo Funding details: Ligue Contre le Cancer Funding details: EC, European Commission Funding details: Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The SUDCAN study was supported by the French Ligue contre le Cancer. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). References: Allemani, C., Weir, H.K., Carreira, H., Harewood, R., Spika, D., Wang, X.S., Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) (2015) Lancet, 385, pp. 977-1010; Bouvier, A.M., Crehange, G., Azelie, C., Cheynel, N., Jouve, J.L., Bedenne, L., Adjuvant treatments for gastric cancer: From practice guidelines to clinical practice (2014) Dig Liver Dis, 46, pp. 72-75; Crocetti, E., Bossard, N., Uhry, Z., Roche, L., Rossi, S., Capocaccai, R., Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material (2016) Eur J Cancer Prev, 25, pp. S3-S8; Cunningham, D., Allum, W.H., Stenning, S.P., Thompson, J.N., Van De-Velde, C.J., Nicolson, M., Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer (2006) N Engl J Med, 355, pp. 11-20; Dassen, A.E., Dikken, J.L., Bosscha, K., Wouters, M.W., Cats, A., Van De-Velde, C.J., Gastric cancer: Decreasing incidence but stable survival in the Netherlands (2014) Acta Oncol, 53, pp. 138-142; De Angelis, R., Francisci, S., Baili, P., Marchesi, F., Roazzi, P., Belot, A., The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis (2009) Eur J Cancer, 45, pp. 909-930; De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5 - A population-based study (2014) Lancet Oncol, 15, pp. 23-34; Faycal, J., Bessaguet, C., Nousbaum, J.B., Cauvin, J.M., Cholet, F., Bideau, K., Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995 (2005) Gastroenterol Clin Biol, 29, pp. 23-32; Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., (2013) GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 11, , Lyon, France: International Agency for Research on Cancer; Herbreteau, E., Jooste, V., Hamza, S., Lepage, C., Faivre, J., Bouvier, A.M., Trends in the management of gastric cancer over a 32-year period: A French population-based study (2015) Gastric Cancer, 18, pp. 129-137; Lambert, R., Guilloux, A., Oshima, A., Pompe-Kirn, V., Bray, F., Parkin, M., Incidence and mortality from stomach cancer in Japan, Slovenia and the USA (2002) Int J Cancer, 97, pp. 811-818; Macdonald, J.S., Smalley, S.R., Benedetti, J., Hundahl, S.A., Estes, N.C., Stemmermann, G.N., Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction (2001) N Engl J Med, 345, pp. 725-730; Micheli, A., Ciampichini, R., Oberaigner, W., Ciccolallo, L., De Vries, E., Izarzugaza, I., The advantage of women in cancer survival: An analysis of EUROCARE-4 data (2009) Eur J Cancer, 45, pp. 1017-1027; Perme, M.P., Stare, J., Esteve, J., On estimation in relative survival (2012) Biometrics, 68, pp. 113-120; Qin, J., Liu, M., Ding, Q., Ji, X., Hao, Y., Wu, X., The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells (2014) Mol Cell Biochem, 395, pp. 99-107; Schlemper, R.J., Itabashi, M., Kato, Y., Lewin, K.J., Riddell, R.H., Shimoda, T., Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists (1997) Lancet, 349, pp. 1725-1729; Strauss, J., Hershman, D.L., Buono, D., Mcbride, R., Clark-Garvey, S., Woodhouse, S.A., Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival (2010) Int J Radiat Oncol Biol Phys, 76, pp. 1404-1412; Uhry, Z., Bossard, N., Remontet, L., Iwaz, J., Roche, L., New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology (2016) Eur J Cancer Prev, 25, pp. S9-S15; Zhao, X.H., Gu, S.Z., Liu, S.X., Pan, B.R., Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues (2003) World J Gastroenterol, 9, pp. 665-669",
year = "2017",
doi = "10.1097/CEJ.0000000000000309",
language = "English",
volume = "26",
pages = "S32--S39",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Trends in net survival from stomach cancer in six European Latin countries: Results from the SUDCAN population-based study

AU - Glória, L.

AU - Bossard, N.

AU - Bouvier, A.-M.

AU - Mayer-Da-Silva, A.

AU - Faivre, J.

AU - Miranda, A.

AU - Group, GRELL EUROCARE-5 Working

AU - De Angelis, Roberta

AU - Mallone, Sandra

AU - Caldora, Massimiliano

AU - Carrani, Eugenio

AU - Francisci, Silvia Giovanna Luisa

AU - Pierannunzio, Daniela

AU - Roazzi, Paolo

AU - Rossi, Silvia

AU - Santaquilani, Mariano

AU - tavilla, andrea

N1 - Cited By :1 Export Date: 11 April 2018 CODEN: EJUPE Correspondence Address: Miranda, A.; Department of Epidemiology, South Regional Cancer Registry (ROR-Sul), Instituto Português de Oncologia de Lisboa, Francisco Gentil, E.P.E, Rua Professor Lima Basto, Portugal; email: amcbpcm@gmail.com Funding details: 20102202 Funding details: Compagnia di San Paolo Funding details: Ligue Contre le Cancer Funding details: EC, European Commission Funding details: Fondazione Cariplo Funding details: RF-2009-1529710 Funding text: The SUDCAN study was supported by the French Ligue contre le Cancer. The EUROCARE study was supported by The Compagnia di San Paolo, Fondazione Cariplo, the Italian Ministry of Health (Ricerca Finalizzata 2009, RF-2009-1529710) and the European Commission (European Action Against Cancer, EPAAC, Joint Action No. 20102202). References: Allemani, C., Weir, H.K., Carreira, H., Harewood, R., Spika, D., Wang, X.S., Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) (2015) Lancet, 385, pp. 977-1010; Bouvier, A.M., Crehange, G., Azelie, C., Cheynel, N., Jouve, J.L., Bedenne, L., Adjuvant treatments for gastric cancer: From practice guidelines to clinical practice (2014) Dig Liver Dis, 46, pp. 72-75; Crocetti, E., Bossard, N., Uhry, Z., Roche, L., Rossi, S., Capocaccai, R., Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material (2016) Eur J Cancer Prev, 25, pp. S3-S8; Cunningham, D., Allum, W.H., Stenning, S.P., Thompson, J.N., Van De-Velde, C.J., Nicolson, M., Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer (2006) N Engl J Med, 355, pp. 11-20; Dassen, A.E., Dikken, J.L., Bosscha, K., Wouters, M.W., Cats, A., Van De-Velde, C.J., Gastric cancer: Decreasing incidence but stable survival in the Netherlands (2014) Acta Oncol, 53, pp. 138-142; De Angelis, R., Francisci, S., Baili, P., Marchesi, F., Roazzi, P., Belot, A., The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis (2009) Eur J Cancer, 45, pp. 909-930; De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5 - A population-based study (2014) Lancet Oncol, 15, pp. 23-34; Faycal, J., Bessaguet, C., Nousbaum, J.B., Cauvin, J.M., Cholet, F., Bideau, K., Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995 (2005) Gastroenterol Clin Biol, 29, pp. 23-32; Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., (2013) GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 11, , Lyon, France: International Agency for Research on Cancer; Herbreteau, E., Jooste, V., Hamza, S., Lepage, C., Faivre, J., Bouvier, A.M., Trends in the management of gastric cancer over a 32-year period: A French population-based study (2015) Gastric Cancer, 18, pp. 129-137; Lambert, R., Guilloux, A., Oshima, A., Pompe-Kirn, V., Bray, F., Parkin, M., Incidence and mortality from stomach cancer in Japan, Slovenia and the USA (2002) Int J Cancer, 97, pp. 811-818; Macdonald, J.S., Smalley, S.R., Benedetti, J., Hundahl, S.A., Estes, N.C., Stemmermann, G.N., Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction (2001) N Engl J Med, 345, pp. 725-730; Micheli, A., Ciampichini, R., Oberaigner, W., Ciccolallo, L., De Vries, E., Izarzugaza, I., The advantage of women in cancer survival: An analysis of EUROCARE-4 data (2009) Eur J Cancer, 45, pp. 1017-1027; Perme, M.P., Stare, J., Esteve, J., On estimation in relative survival (2012) Biometrics, 68, pp. 113-120; Qin, J., Liu, M., Ding, Q., Ji, X., Hao, Y., Wu, X., The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells (2014) Mol Cell Biochem, 395, pp. 99-107; Schlemper, R.J., Itabashi, M., Kato, Y., Lewin, K.J., Riddell, R.H., Shimoda, T., Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists (1997) Lancet, 349, pp. 1725-1729; Strauss, J., Hershman, D.L., Buono, D., Mcbride, R., Clark-Garvey, S., Woodhouse, S.A., Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival (2010) Int J Radiat Oncol Biol Phys, 76, pp. 1404-1412; Uhry, Z., Bossard, N., Remontet, L., Iwaz, J., Roche, L., New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology (2016) Eur J Cancer Prev, 25, pp. S9-S15; Zhao, X.H., Gu, S.Z., Liu, S.X., Pan, B.R., Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues (2003) World J Gastroenterol, 9, pp. 665-669

PY - 2017

Y1 - 2017

N2 - Gastric cancers are a clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from gastric cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and explore the trends in net survival and in the dynamics of the excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These trend analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in agestandardized net survival for stomach cancer (2000-2004). The 5-year net survival ranged between 26 (Spain) and 32% (Italy). There was a small increase in the age-standardized net survival at 1 year between 1992 and 2004. The increase was also observed in the 5-year net survival, except in France, where the increase was less marked. A slight decrease in the EMR between 1992 and 2004 was limited to the 24 months after diagnosis. In addition, the decrease in the EMR was the same whatever the year of diagnosis. There were minor differences in survival from stomach cancer between European Latin countries. A slight improvement in the 5-year net survival was observed in all countries and the major gain was observed during the 24 months after diagnosis. Development of innovative treatments is needed to improve the prognosis. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

AB - Gastric cancers are a clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from gastric cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and explore the trends in net survival and in the dynamics of the excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These trend analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in agestandardized net survival for stomach cancer (2000-2004). The 5-year net survival ranged between 26 (Spain) and 32% (Italy). There was a small increase in the age-standardized net survival at 1 year between 1992 and 2004. The increase was also observed in the 5-year net survival, except in France, where the increase was less marked. A slight decrease in the EMR between 1992 and 2004 was limited to the 24 months after diagnosis. In addition, the decrease in the EMR was the same whatever the year of diagnosis. There were minor differences in survival from stomach cancer between European Latin countries. A slight improvement in the 5-year net survival was observed in all countries and the major gain was observed during the 24 months after diagnosis. Development of innovative treatments is needed to improve the prognosis. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

KW - Cancer registries

KW - Europe

KW - Excess mortality rate

KW - Net survival

KW - Stomach cancer

KW - Trend analysis

KW - adolescent

KW - adult

KW - aged

KW - Article

KW - Belgium

KW - cancer mortality

KW - cancer prognosis

KW - cancer survival

KW - controlled study

KW - experimental therapy

KW - France

KW - human

KW - Italy

KW - major clinical study

KW - multicenter study

KW - population research

KW - Portugal

KW - priority journal

KW - Spain

KW - stomach cancer

KW - Switzerland

KW - time

KW - epidemiology

KW - factual database

KW - female

KW - health survey

KW - male

KW - middle aged

KW - mortality

KW - procedures

KW - register

KW - stomach tumor

KW - survival rate

KW - trends

KW - very elderly

KW - young adult

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Databases, Factual

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Population Surveillance

KW - Registries

KW - Stomach Neoplasms

KW - Survival Rate

KW - Young Adult

U2 - 10.1097/CEJ.0000000000000309

DO - 10.1097/CEJ.0000000000000309

M3 - Article

VL - 26

SP - S32-S39

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 1

ER -